Most recent update: Tuesday, April 7, 2020 - 09:55

Bariatric News - Cookies & privacy policy

You are here

sleeve gastrectomy

Surgery before diabetes develops leads to greater weight loss

Patients with obesity may lose more weight if they undergo bariatric surgery before they develop diabetes, according to a study, accepted for presentation at ENDO 2020 (the Endocrine Society's annual meeting that was cancelled due to the COVIUD-19 pandemic), that will be published in a special supplemental section of the Journal of the Endocrine Society.

Both obesity and diabetes are common, with more than one-third of US adults are affected by these two conditions. Among patients that have obesity and diabetes, bariatric surgery can lead to remission of both of these diseases.

Bypass patients maintain 20% weight loss vs 5% non-surgical

People with severe obesity who underwent bariatric surgery maintained significantly more weight loss at five years than those who did not have surgery, according to a Kaiser Permanente study. Although some weight regain was common after surgery, regain to within 5% of baseline was rare, especially in patients who had gastric bypass instead of sleeve gastrectomy.

More operations or interventions after gastric bypass than sleeve

A study involving tens of thousands of bariatric surgery patients found that RYGB patients were significantly more likely than sleeve gastrectomy (SG) patients to return to hospital in the years following surgery for an operation or intervention. According to the authors, the study is one of the largest bariatric surgery studies ever done and the first study of its size to focus on health problems years after the procedure.

Gastric bypass is superior to sleeve gastrectomy for T2DM remission

Gastric bypass is superior to sleeve gastrectomy for remission of type 2 diabetes at one year after surgery, according to a study led by researchers from Morbid Obesity Centre, Vestfold Hospital Trust, Tønsberg, Norway. The outcomes from the Obesity Surgery in Tønsberg (OSEBERG) study also showed that the two procedures had a similar beneficial effect on β-cell function, but they noted that the use of gastric bypass as the preferred bariatric procedure for patients with obesity and type 2 diabetes could improve diabetes care and reduce related societal costs.

Clear need for high-dosed multivitamin supplementation for LSG patients

There is a clear need for high-dosed multivitamin supplementation for patients who have had a sleeve gastrectomy, according to the results from a randomised controlled study carried by researchers from Vitalys Clinic and Rijnstate Hospital, Arnhem and Wageningen University, Wageningen, The Netherlands.

Patients with obesity have better outcomes than severe patients

A study has found that bariatric surgery improves or resolves diabetes, reduces heart attacks and strokes and produces significant weight loss in patients who are 50 to 70lbs overweight (BMI<35) and that these patients are even more likely to reach a healthy weight, have a higher quality of life and improve or resolve their type 2 diabetes. The findings were presented today by researchers from the University of Michigan (U-M) at the 36th American Society for Metabolic and Bariatric Surgery (ASMBS) Annual Meeting at ObesityWeek 2019.

RYGB offers better weight loss but higher readmission rates vs LSG

One-year outcomes from over 47,000 Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy procedures has reported that RYGB resulted in a higher rate of patients with total weight loss (TWL) >20% (95.8% vs 84.6%, p<0.001). However, there were no significant differences between the two procedures in the rate of severe complications (2.6% vs 2.4%, p=0.382) and 30-day mortality (0.04% vs 0.03%, p=0.821), although readmission rates were higher post-RYGB (4.3% vs 3.4%, p<0.001).

SG results in weight loss and co-morbidity resolution up to ten years

Sleeve gastrectomy (SG) results sustained weight loss (WL) and co-morbidity resolution up to ten years post-operatively and although a notable portion of patients experience weight regain (WR), mean percent weight loss (%WL) exceeds 30%, translating in adequate weight loss also in the long term, according to researchers from Sapienza University of Rome, Rome, Italy.

Patients report improvements in anxiety and depression after SG

A majority of patients who had a sleeve gastrectomy (SG) reported an improvement in anxiety and depression, according to a study by researchers from the University at Buffalo. The investigators noted that anti-depressant and anti-anxiety medication regimens were altered in approximately one-third of cases and were primarily dose decrease or discontinuation, and where symptoms improved the medications were decreased or discontinued in over 90%.

Sleeve gastrectomy increasing among US patients with ESKD

A recent analysis of trends in weight loss surgery among patients with end-stage kidney disease (ESKD) and obesity reveals that sleeve gastrectomy is safe, and its use has increased in recent years and suggest that kidney failure should not be considered a contraindication for bariatric surgery.

Subscribe to RSS - sleeve gastrectomy